In C9orf72-linked ALS/FTD, Nrf2 activation alleviates key molecular pathologies by reducing DPR accumulation and RNA foci, restoring nuclear TDP-43, and enhancing RNA quality control pathways such as NMD and R-loop resolution. Here, NFE2L2 is linked to amyotrophic lateral sclerosis.